Order of the Supreme Court of India in the matter of Network of People Living With HIV/AIDS & Others Vs Union of India & Others dated 24/02/2025. The Supreme Court (SC), February 24, 2025 has directed all states to file their affidavits addressing concerns raised about antiretroviral therapy (ART) drugs …
Dora Akunyili is director-general of Nigeria's National Agency for Food and Drug Administration and Control (NAFDAC). Since her appointment in 2001, she has led a successful crusade against counterfeit pharmaceuticals, which are responsible for millions of deaths worldwide each year.
FDA Officials Say They Have Found A Clear Link Between Tainted Heparin And 81 Deaths In US Gardiner Harris Washington: A contaminated blood thinner from China has been found in drug supplies in 11 countries, and federal officials said Monday they had discovered a clear link between the contaminant and …
Ranbaxy on Tuesday said that it has entered into a business alliance with Orchid Chemicals & Pharmaceuticals, involving multiple geographies and therapies for both finished dosage formulations and active pharmaceutical ingredients (raw materials). However, sources said the option of acquiring additional equity in Orchid, and announcing an open offer at …
A parliamentary panel has pulled up the Department of Chemicals and Petrochemicals for delay in finalising the National Pharmaceutical Policy, 2006. In its report, the Parliamentary Standing Committee on Chemicals and Fertilizers has observed that despite its recommendation for finalising the policy, the department remained static on such a crucial …
The Parliamentary Standing Committee on Chemical and Fertiliser has slammed the Department of Chemicals and Petrochemicals over the delay in finalising National Pharmaceutical Policy (NPP) 2006. The policy, aimed at making drugs cheaper, has been delayed due to strong opposition from the industry. While the policy will bring more number …
Mythology speaks about devas (Gods) and asuras (devils) churning the sea for amrit that will give them immortality. Today, scientists at the Cochin University of Science and Technology (Cusat) are churning the oceans for drugs capable of fighting many terminal diseases, including HIV and cancer. "The sea is a treasure …
Sixteen months after it was set up, an inter-ministerial group is set to finalise a new pharma policy for the country. A group of ministers (GoM) headed by Agriculture Minister Sharad Pawar is scheduled to meet on April 30 to finalise its recommendations for a policy that would attempt to …
Ranbaxy is understood to be finalizing a plan to announce an open offer for Chennai-based Orchid Chemicals. Solrex, believed to be backed by Ranbaxy's promoters, has already bought 11.3% stake in Orchid, and according to market sources, later upped it to 14.7%. This is marginally less than the 15% limit …
finally, Hannah Poling got justice. A federal court in the us recently asked authorities to compensate the Georgia girl who became autistic after getting vaccine shots in 2002. She was 18 months old then. Many hope the ruling will also influence nearly 5,000 similar cases at the National Vaccine Injury …
disease-causing bacteria are gaining resistance to antibiotics by producing enzymes that deactivate them. A study has decoded the structure of the enzyme that helps bacteria gain resistance to a specific class of antibiotics. This is crucial because this class of antibiotics was the only remaining lot so fat to be …
The country's largest drug maker Ranbaxy Laboratories today announced the launch of bonista teriparatide injection used in the treatment of osteoporosis (thinning of bones) in collaboration with Hyderabad-based Virchow Biotech. Ranbaxy has become the first company in the world to launch this bio-generic product, the company said in a filing …
Ranbaxy Laboratories Ltd has announced the launch of BONISTA- Teriparatide injection for the treatment of Osteoporosis, in collaboration with the Hyderabad-based Virchow Biotech Pvt Ltd. Ranbaxy is the first company to launch this bio-generic product in the world. Commenting on the launch of the product, Mr Sanjeev I. Dani, Senior …
MP's small and medium drug manufacturers, which are mainly located in Indore and Pithampur, are crying themselves hoarse due to the huge business losses being incurred due to non clearance and non-approvals from the drug controller's department. The post of the drug controller has been lying vacant for the last …
In a move likely to influence future drug price regulation in the country, the National Pharmaceutical Pricing Authority (NPPA) has started a process to understand how other countries carry out this function. The authority has already studied the relevant regulatory systems in at least eight major countries. It has also …
A drug commonly used to fight AIDS appears to nearly double the risk of a heart attack, researchers said. In a study published online in The Lancet medical journal, European researchers said that the antiretroviral abacavir, included as part of many anti-AIDS regimens worldwide, almost doubled patients' chances of heart …
The model for kala azar eradication is a cross-sectoral public-private partnership, writes Kavita Khanna in the second of a two-part series Globally, kala azar is the second largest parasitic killer after malaria. In India, Bihar is the epicentre of kala azar, home to, as per the state Kala Azar Task …
Justice S Ravinder Bhat of the Delhi High Court is a hero to some. His decision last month to allow generic drug manufacturer Cipla to continue manufacturing its version of Roche's patented lung cancer drug erlotinib (sold as Tarceva in India) has made him the toast of public health activists …
Novartis India is up in arms against a two-month old decision of the National Pharmaceutical Pricing Authority (NPPA) to reduce the price of its flagship brand Voveran on public interest grounds. The annual sales of Voveran, the brand name for pain reliever medicine diclofenac, exceed Rs 100 crore and account …
